companies / salviabio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-08 json
| total_raised | 53,000,00053.0M | ○ |
|---|---|---|
| founded | 2017 | |
| hq | Eindhoven, Netherlands | |
| industry | unknown | |
| stage | series-b+ |
Salvia BioElectronics develops a paper-thin implant that uses neuromodulation to reduce the frequency and intensity of chronic migraine and cluster headaches. It is built for severe migraine and cluster-headache patients. Its ultra-thin bioelectronic implant delivers gentle pulses to the nerves involved in migraine.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-04-01 | grant | 2,700,0002.7M | null | ○ |
Cloudflare, reCAPTCHA, Google Sign-in, Google Tag Manager
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |